Sangui Biotech International, Inc.
SGBI · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $319 | $735 | $2,086 | $5,227 |
| - Cash | $0 | $3 | $30 | $30 |
| + Debt | $0 | $814 | $825 | $820 |
| Enterprise Value | $319 | $1,547 | $2,881 | $6,017 |
| Revenue | $133 | $93 | $69 | $66 |
| % Growth | 43.3% | 34.5% | 5.5% | – |
| Gross Profit | $133 | $93 | $69 | $66 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$1 | -$88 | -$22 | -$165 |
| % Margin | -1.1% | -94.3% | -32.5% | -252% |
| Net Income | -$12 | -$148 | -$59 | -$236 |
| % Margin | -9.1% | -158.8% | -85.7% | -359.8% |
| EPS Diluted | -0 | -0.001 | -0 | -0.001 |
| % Growth | 85.7% | -133.3% | 75% | – |
| Operating Cash Flow | – | -$12 | -$140 | -$146 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$12 | -$140 | -$146 |